MedTrace Logo

Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation

NCT00178243 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2006-09-08

No results posted yet for this study

Summary

A study is being conducted by the University of Rochester Cancer Center (URCC) in which patients with liver cancer will be treated with high dose conformal radiation therapy. This type of radiation uses new techniques which aim the radiation to the sites of disease allowing the tumor to receive a high dose and the surrounding normal liver tissue to receive a low enough dose that the normal tissue should remain free from injury.

The purpose of the study is to determine if the conformal radiation therapy is safe, tolerable and effective in treating liver cancer and to determine the side effects caused by this treatment. A second objective is to determine if the levels of a special type of protein (called cytokines) found in the blood are related to this treatment.

Conditions

  • Liver Neoplasms
  • Neoplasm Metastasis

Interventions

PROCEDURE

3D Conformal Radiation Therapy and Radiosurgery

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Paul Okunieff, MD · Universtiy of Rochester, Dept of Radiation Oncology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00178243 on ClinicalTrials.gov